Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2007
06/21/2007US20070141056 Growth factor homolog zvegf3
06/21/2007US20070141053 Treatment of inflammatory respiratory diseases
06/21/2007US20070141044 Method for treating cancer patients undergoing chemotherapy
06/21/2007US20070141043 Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular Conditions
06/21/2007US20070141042 Methods for the treatment and prevention of diseases of biological conduits
06/21/2007US20070141041 Enzymes for reduced immunological stress
06/21/2007US20070141040 Protein kinase C peptide modulators of angiogenesis
06/21/2007US20070141033 Purging of cells using viruses
06/21/2007US20070141029 Methods of gene therapy for treating disorders of the ear by adminstering a vector encoding an antonal-associated factor
06/21/2007US20070141026 Immunotherapy in cancer treatment
06/21/2007US20070141025 Compositions and methods for cancer immunotherapy
06/21/2007US20070141024 Mammalian cytokine; reagents and methods
06/21/2007US20070141023 Assays and methods using biomarkers
06/21/2007US20070141022 Polymeric delivery agents and delivery agent compounds
06/21/2007US20070141021 Methylmaleimidyl polymer derivatives
06/21/2007US20070141009 Sirna mediated post-transriptional gene silencing of genes involved in alopecia
06/21/2007US20070140979 Method for accelerating the rate of mucociliary clearance
06/21/2007US20070140976 Aqueous inhalation pharmaceutical composition
06/21/2007US20070140972 Targeting compositions and preparation therof
06/21/2007US20070140970 Cell targeting conjugates
06/21/2007US20070140965 Methods to ameliorate and image angioplasty-induced vascular injury
06/21/2007US20070140964 Cytokine receptor zcytor17 multimers
06/21/2007US20070140963 Cytokine receptor zcytor17 multimers
06/21/2007DE102005061329A1 Mittel zur Anwendung bei Blutzuckerstoffwechselstörungen einschließlich Diabetes Means for use in blood sugar metabolism disorders including diabetes
06/21/2007DE102005060920A1 Peptide für die Wechselwirkung mit alpha-helikalen Coiled-Coil-Strukturen und/oder Coiled-Coil-Sequenzen, davon abgeleitete Mittel und ihre Verwendung Peptides for interaction with alpha-helical coiled-coil structures and / or the coiled-coil sequences derived therefrom and their use
06/21/2007CA2633468A1 Novel neurotrophic factor protein and uses thereof
06/21/2007CA2633255A1 Diagnosis and prognosis of colorectal cancer
06/21/2007CA2633224A1 Non-natural amino acids and neurotensin analogues thereof
06/21/2007CA2633211A1 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer
06/21/2007CA2633201A1 Skin care compositions and treatments
06/21/2007CA2633180A1 Methods of treating obesity using enterostatin
06/21/2007CA2633087A1 Adenoviral expression vectors
06/21/2007CA2633043A1 Use of eif-5a to kill multiple myeloma cells
06/21/2007CA2632876A1 Bovine osteopontin formulations for the improvement of the wound healing process
06/21/2007CA2632451A1 Cell penetrating peptides for intracellular delivery of molecules
06/21/2007CA2632024A1 Treatment of multiple sclerosis using interferon-tau
06/21/2007CA2627939A1 New chemokine antagonists
06/20/2007EP1798287A2 Mammalian cell membrane proteins and related reagents
06/20/2007EP1798286A2 Mammalian cell membrane proteins and related reagents
06/20/2007EP1798285A1 Methods and medicament for inhibition the expression of a defined gene
06/20/2007EP1798239A2 G-protein coupled receptors and uses therefor
06/20/2007EP1798238A1 Synthetic peptides which reduce or eliminate bags formed under the lower rim of the eyes and use thereof in cosmetic or dermopharmaceutical compositions
06/20/2007EP1797902A2 Particles for inhalation having sustained release properties
06/20/2007EP1797898A1 Preventive/therapeutic drug for arteriosclerosis
06/20/2007EP1797892A1 Use of modified cyclosporins for the treatment of HCV disorders
06/20/2007EP1797891A1 Total enteral nutritious composition
06/20/2007EP1797873A2 Compressed microparticles for dry injection
06/20/2007EP1797869A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation
06/20/2007EP1797192A1 Modified proteins
06/20/2007EP1797123A1 COMPLEMENTARY PEPTIDES FOR ß-AMYLOID 29-42 PEPTIDE
06/20/2007EP1797120A1 Deglycosylated and desialidated long pentraxin ptx3
06/20/2007EP1797119A2 Method of reducing the effects of alpha beta and compositions therefore
06/20/2007EP1797114A2 Cupredoxin derived transport agents and methods of use thereof
06/20/2007EP1797112A2 Inhibitors of hepatitits c virus
06/20/2007EP1797111A1 Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease
06/20/2007EP1797110A1 Antibacterial amide macrocycles iv
06/20/2007EP1797109A2 Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
06/20/2007EP1796725A1 Treatment or prevention of unscheluded bleeding in women on progestogen containing medication
06/20/2007EP1796716A2 Chemokine combinations to mobilize progenitor/stem cells
06/20/2007EP1796715A2 USE OF TGF-ß ANTAGONISTS TO LIMIT NEPHROTOXICITY OF IMMUNOSUPPRESSIVE AGENTS
06/20/2007EP1796714A2 Methods of inhibiting cell death or inflammation in a mammal
06/20/2007EP1796713A1 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response
06/20/2007EP1796711A2 Herstatin or intron 8-encoded domain thereof for modulating signaling mediated by igf-1 receptor and erbb receptors
06/20/2007EP1796710A2 Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis
06/20/2007EP1796709A2 Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels
06/20/2007EP1796708A2 Improved apo e analogs and methods for their use
06/20/2007EP1796707A2 Peptides that selectively home to heart vasculature and related conjugates and methods
06/20/2007EP1796694A2 Methods to enhance hemodynamic stability using oxygen carrying compositions
06/20/2007EP1796693A2 Implantable tissue compositions and method
06/20/2007EP1796687A2 Combination therapy for controlled carbohydrate digestion
06/20/2007EP1796680A2 Methods of treating symptoms of multiple sclerosis using vitamin d and related compounds
06/20/2007EP1796647A2 Stable pegylated interferon formulation
06/20/2007EP1796646A1 Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods
06/20/2007EP1796640A1 Vascular tunneler
06/20/2007EP1715887B1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and use thereof
06/20/2007EP1623036A4 Identification of novel nogo-receptors and methods related thereto
06/20/2007EP1594517B1 Compositions for the treatment of gastrointestinal disorders
06/20/2007EP1485410B1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
06/20/2007EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier
06/20/2007EP1358353B1 Identification of genetic determinants of polymorphic cyp3a5 expression
06/20/2007EP1281083B1 Methods for detecting inflammation and inflammatory conditions
06/20/2007EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use
06/20/2007EP1228231B1 Mammalian-type glycosylation in plants
06/20/2007EP1179010B1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
06/20/2007EP1154796B1 Novel albumin-free factor viii formulations
06/20/2007EP1124946B1 Glycosylated proteins having reduced allergenicity
06/20/2007EP1105408B1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
06/20/2007EP1012329B1 Diagnosis and treatment of myocardial failure
06/20/2007EP0789593B1 Yeast-based delivery vehicles
06/20/2007EP0745121B1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
06/20/2007CN1985169A Use of TWEAK modulators and inhibitors for the treatment of neurological conditions
06/20/2007CN1985000A T-cell death-inducing epitopes
06/20/2007CN1984928A Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
06/20/2007CN1984925A Genes and polypeptides relating to prostate cancers
06/20/2007CN1984924A Methods for increasing conjugation of protein and polyethylene glycol (PEG)
06/20/2007CN1984923A Methods for treating and diagnosing cancer with WNT inhibitory factor-1 (WIF1)
06/20/2007CN1984922A Substituted prolines as inhibitors of hepatitis c virus NS3 serine protease
06/20/2007CN1984919A Identification of a novel bitter taste receptor, T2R76
06/20/2007CN1984675A Pharmaceutical compositions comprising botulinum neurotoxin, a non ionic surfactant, sodium chloride and sucrose
06/20/2007CN1984674A Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides
1 ... 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 ... 3163